Deucravacitinib is a TYK2 inhibitor being investigated as a treatment for psoriasis. it sold under the brand name Sotyktu. A drug being investigated for treating psoriasis, a chronic autoimmune skin condition. Reference standards of Deucravacitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
6-(Cyclopropanecarboxamido)-4-((2-hydroxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
Catalogue No.:PA STI 089869
CAS :
Molecular Formula : C19H17D3N8O3
Molecular Weight : 411.44
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
